[ET Net News Agency, 6 March 2026] REMEGEN (09995) rose 10.3% to HK$84.8.
It hits an intra-day high of HK$84.8, breaking above the 100-D SMA of HK$84.658, and an
intra-day low of HK$75.3. The total shares traded was 6.46 million, with a value of
HK$531.01m. The active buy/sell ratio is 70:30, with net buying turnover of HK$204.65m.
DBS VICKERS (HK) accounts for greatest net responsive buying turnover of HK$3.13m, with
volume weighted average price of HK$82.653. CITIGROUP GLOBAL accounts for greatest net
responsive selling turnover of HK$43.56m, with volume weighted average price of HK$82.509.
The stock has risen a combined 18% over the past 2 consecutive trading days.

Basic Information
=================

----------------------------------
Nominal 84.800 % Chg +10.27%
High 84.800 Low 75.300
Shares Tr 6.46m Turnover 531.01m
10-D SMA 78.485 %H.V 46.671
20-D SMA 79.655 VWAP 82.178
50-D SMA 83.357 RSI14 55.848
----------------------------------
Status: Breaking above the 100-D SMA, active buy/sell ratio is 70:30, with net buying
turnover of HK$204.65m, rising a combined 18% over the past 2 consecutive trading days

Performance of stocks in the same sector or of relevance
========================================================

Stock (Code) Price (HK$) Change (%)
-----------------------------------------------
REMEGEN (09995) 84.80 +10.27
HUTCHMED (00013) 22.06 +4.75
INNOVENT BIO (01801) 83.30 +6.18
XTALPI (02228) 10.04 +3.19
WUXI BIO (02269) 35.54 +0.28
WUXI APPTEC (02359) 111.40 +2.67
TRANSTHERA-B (02617) 89.90 +40.25
BEONE MEDICINES (06160) 182.50 +2.76
DUALITYBIO-B (09606) 306.60 +5.29
AKESO (09926) 106.60 +4.51
-----------------------------------------------
(ed)